Study on the molecular mechanism of UBA52 and BARD1 regulating hepatocellular carcinoma through the PI3 K/AKT signaling pathway
Abstract Background Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths globally, with its development closely related to complex molecular mechanisms such as gene mutations and abnormal signaling pathways. However, the specific roles of many key genes remain unclear...
Saved in:
| Main Authors: | Chenrui Yang, Yanzhong Zhang, Yajuan Liu, Xiaoyong Wu, Fangyuan Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-05-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02600-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
UBA 200
by: Fernando Gandolfi
Published: (2022-12-01) -
NAT10 promotes hepatocellular carcinoma progression by modulating the ac4C-DDIAS-PI3K-Akt axis
by: Yue Tao, et al.
Published: (2025-05-01) -
Multi-omics analysis identifies UBA family as potential pan-cancer biomarkers for tumor prognosis and immune microenvironment infiltration
by: Haibin Wang, et al.
Published: (2025-02-01) -
Digoxigenin activates autophagy in hepatocellular carcinoma cells by regulating the PI3K/AKT/mTOR pathway
by: Mengqing Ma, et al.
Published: (2024-12-01) -
Auranofin amplifies schisandrin A-induced apoptosis through ROS generation and inhibiting the PI3K/Akt pathway in hepatocellular carcinoma
by: Hyun Hwangbo, et al.
Published: (2025-06-01)